EBS vs BIOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 09, 2026

EBS

32.7
AI Score
VS
BIOA Wins

BIOA

48.4
AI Score

Investment Advisor Scores

EBS

33score
Recommendation
AVOID NEW MONEY

BIOA

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EBS BIOA Winner
Forward P/E 22.9885 0 Tie
PEG Ratio 0.3835 0 Tie
Revenue Growth 66.3% 1.6% EBS
Earnings Growth -93.8% 0.0% BIOA
Tradestie Score 32.7/100 48.4/100 BIOA
Profit Margin -23.0% 0.0% BIOA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BIOA

Relative Price Performance (Last 90 Days)

EBS 1M: +19.9% · 3M: -15.4% BIOA 1M: -32.3% · 3M: -74.5%

Current Technical Phase

EBS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.9 · Price: $6.81

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -40.1%), weak momentum, RSI 22

RSI (14): 22.4 · Price: $6.21

Fundamentals Snapshot

Metric EBS BIOA
Market Cap — —
Forward P/E 6.5 -2.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.7% 0.0%
Gross Margin 0.5% -7.5%
Operating Margin 0.3% -12.0%
EPS -3.40 -2.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.